Biosante Pharmaceuticals Inc (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Recs

1
Player Avatar usubanas (99.71) Submitted: 2/7/2012 10:00:53 AM : Underperform Start Price: $0.88 BPAX Score: +10.83

time to throw in the towel

Report this Post 1 Comment
Member Avatar seattle1218 (< 20) Submitted: 2/14/2012 9:07:20 PM
Recs: 0

ha ha ha ha ha!!!!! lol

Report this Post

Featured Broker Partners


Advertisement